Simos Simeonidis
PhD, Chairman, CEO & Co-Founder
Delsona Therapeutics

Dr. Simos Simeonidis is the CEO, Chairman of the Board and Co-Founder of Delsona Therapeutics, a healthcare company focusing on treatments for neurodegenerative diseases and oncology. Dr. Simeonidis’s career in healthcare spans more than 25 years, including as an investor in private and public healthcare companies, as a senior biotechnology analyst for a number of investment banks, as a biopharmaceutical executive, board member and as a molecular biologist at Harvard and Columbia Medical Schools. 

Most recently, he was Managing Partner, co-CEO and co-CIO of Ally Bridge Group, a healthcare dedicated investment firm investing in private and public companies in the life sciences space. Prior to Ally Bridge Group, he was Partner, Senior Managing Director and Co-Head of Research of Sarissa Capital Management, a biotechnology-focused investment firm. Prior to joining Sarissa, he was a Managing Director and Senior Biotechnology Analyst at the Royal Bank of Canada (RBC) in New York and had spent more than a decade covering the biotechnology sector as an analyst at a number of investment banks, including Cowen and Company, First Albany Capital and Morgan Stanley. In addition to his investment management and financial expertise, Dr. Simeonidis combines both biopharmaceutical industry and biomedical research expertise, having worked at Novartis in Business Development and Strategic Planning, and prior to his corporate career, having served as a faculty member at Harvard Medical School. 

Dr. Simeonidis received his BS degree in Biology from Loyola University Chicago, and his MA, MPhil and PhD degrees in Cellular, Molecular and Biophysical Sciences from Columbia University’s College of Physicians & Surgeons. He completed his Postdoctoral Fellowship at the laboratory of Professor Tucker Collins at Harvard Medical School and the Brigham and Women’s Hospital, where he worked on the transcriptional regulation of gene expression. Dr. Simeonidis also holds an MBA in Healthcare Management at the Wharton School of the University of Pennsylvania